Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1

Status

Completed 10Active not recruiting 5Terminated 2Recruiting 2Withdrawn 1Not yet recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 11Breast 10Gastrointestinal 9Other solid neoplasm 7Thoracic 6Tumor-Agnostic 3Other 3CNS 3Sarcoma 2Other hematologic neoplasm 2Lymphoid 2Gynecologic 2Dermatologic 2Other neoplasm 1

Conditions

Hematologic Neoplasms 2

Interventions

venetoclax 193Cyclophosphamide 124Azacitidine 113Cytarabine 108fludarabine 92Specimen Handling 73Biopsy 54Daunorubicin 43Methotrexate 40Dexamethasone 37Rituximab 34blinatumomab 33Vincristine 31Decitabine 31fludarabine phosphate 30Injections 29Granulocyte Colony-Stimulating Factor 28Magnetic Resonance Spectroscopy 27Whole-Body Irradiation 26obinutuzumab 25Idarubicin 25acalabrutinib 23Mycophenolic Acid 23Prednisone 22Melphalan 21Busulfan 21gilteritinib 19Stem Cell Transplantation 19Doxorubicin 19ibrutinib 18

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recruiting × Methods × Other hematologic neoplasm × Clear all
NCT07186192 2026-01-28

Digital Health Intervention for Self-Management and Telemonitoring in Chimeric Antigen Receptor (CAR-T) Therapy

City of Hope Medical Center

Phase 3 Recruiting
190 enrolled
Other hematologic neoplasm

Hematologic Neoplasms

NCT06501040 2025-07-16

Increasing Knowledge and Interest in Cancer Clinical Trials

Barbara Ann Karmanos Cancer Institute

Phase NA Recruiting
384 enrolled
Other hematologic neoplasm

Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡